The 700,000 square-foot facility is expected to create 400 high-wage manufacturing jobs once operational.

The order pushes drug companies to reduce drug prices in the United States to fall in line with other countries around the ...

Identifying the priorities that translate to strong business outcomes—and separating the top performers from the average ...

Merck Animal Health will invest $895 million to expand vaccine manufacturing and R&D in Kansas, while Lilly is committing ...

Proposed cuts to Medicaid will have significant impacts on the health industry. One area that will be heavily impacted by ...

On Sunday, President Trump posted to Truth Social that he planned on implementing a most-favored-nation policy for ...

The Avmapki Fakzynja Co-Pack marks the first FDA-approved treatment for adult patients with KRAS-mutated recurrent low-grade ...

While expressing a desire for revenue growth is common, understanding the “why” behind that intention is crucial. Delving ...

Beyond technology, regulations weigh heavily on the minds of pharma executives. Four out of 10 leaders believe regulatory ...

Will Pih, co-founder, Two Labs, explains how ongoing regulatory uncertainty is slowing clinical trial activity and hiring ...

Under terms of the deal, Alchemab will lead early Phase I trials for ATLX-1282 in amyotrophic lateral sclerosis, while Lilly ...

Interim results from the ongoing Phase III ASSURE trial demonstrated that Livdelzi maintained a consistent biochemical ...